Modern Diagnostic & Research Centre
smelistedAbout the company
Modern Diagnostic & Research Centre is a service provider in diagnostic and related healthcare tests in India. The company delivers diagnostic services that include core testing, disease diagnosis, prevention, and monitoring for individual patients, hospitals, healthcare providers, and corporate clients. The company offers services through pathology and clinical laboratories, as well as imaging services like ultrasound, colour Doppler, CT scan, MRI scan, digital X-ray, mammography, ECG, PFT, and other specialised diagnostic tests. Currently, it operates 21 centres, which consist of 18 laboratories and three diagnostic centres across 8 states with advanced tech like 3T MRI, 128-slice CT, NGS, and PACS for digital imaging. It also provides additional services, such as online access to test reports, home sample collection, and customised test packages for both individual and institutional clients. As of June 30, 2025, Pathology made up 80.70% of revenue from operations, while radiology made up 19.30%. Domestic revenue was mainly from Haryana, which contributed 65.80%. India accounted for 96.70% of the revenue, and the remainder came from various countries such as Kenya, Nepal, Ethiopia, Uganda, and Dubai. In FY25, it conducted 3.24 crore tests for 13.69 lakh patients, with B2C revenues forming 48.66% and B2B 51.34%.
Strengths
Risks
Financial performance (₹ Cr)
Subscription breakup (final, times)
IPO Roadmap / Timeline
IPO Opens
Completed31 Dec 2025Bidding starts for all investor categories
IPO Closes
Completed02 Jan 2026Last day to place your bid
Basis of Allotment
Completed05 Jan 2026Share allotment finalised
Refund Initiation
Completed06 Jan 2026Refunds credited for non-allottees
Credit to Demat
Completed06 Jan 2026Allotted shares credited to demat account
Listing on Exchange
Completed07 Jan 2026Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
Lot size & minimum investment
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 1600 | ₹144,000 | 1 | ₹144,000 | 1 lot only |
| HNI | 2 | 3200 | ₹288,000 | 2 | ₹288,000 | Min 2 lots |
Shares reserved per category & allotment probability
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 2,114,286 | 18.5 | 0 | 0.00x | 100% |
| NII | 15% | 634,286 | 5.55 | 0 | 0.00x | 100% |
| Retail | 35% | 1,480,000 | 12.95 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).
